Many patients who achieved clear skin with tapinarof treatment maintained low disease activity after a treatment-free interval.
Patients with specific dermatological immune-mediated inflammatory diseases are not at increased risk of developing severe COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback